BAYER PHARMA AKTIENGELLSCHAFT

City:

BERLIN

Country:

Germany

Published Applications:

Last publication date:

2022-05-05

Patent Grants:

Last grant date:

2023-08-01

Top Inventors for applications by BAYER PHARMA AKTIENGELLSCHAFT

These are the the leading inventors for applications assigned to BAYER PHARMA AKTIENGELLSCHAFT:

Andreas Janzer 6 Berlin, Germany
Martina SCHÄFER 6 Berlin, Germany
Claudia MERZ 6 Berlin, Germany
Judith Günther 6 Berlin, Germany

Sherif El SHEIKH 6 Mülheim/Ruhr, Germany
Duy Nguyen 6 Berlin, Germany
Sven CHRISTIAN 6 Berlin, Germany
Katja Zimmermann 6 Dusseldorf, Germany

Judith GÜNTHER 6 Berlin, Germany
Michael NIEHUES 6 Berlin, Germany
Stefan Nikolaus GRADL 6 Berlin, Germany
Timo Stellfeld 6 Berlin, Germany

Knut Eis 6 Berlin, Germany
Martina Schäfer 6 Berlin, Germany
Steven James Ferrara 6 Cambridge, MA United States
David B. SYKES 6 Cambridge, MA United States

Kery LIU 5 Beijing, China
Han-jie ZHOU 5 Foster City, CA United States
Changjia ZHAO 5 Beijing, China
Thomas MÜLLER 4 Langenfeld, Germany

Michael KRÖBER 4 Berlin, Germany
Thomas Müller 4 Langenfeld, Germany
Carl Friedrich Nising 4 Leverkusen, Germany
Michael Kröber 3 Berlin, Germany

Thomas FAUPEL 2 Berlin, Germany
Thomas MUELLER 2 Langenfeld, Germany
Simon Anthony HERBERT 2 Berlin, Germany
Jörg KNÄBLEIN 2 Berlin, Germany

Sherif El Sheikh 2 Ruhr, Germany
Jörg Knäblein 2 Berlin, Germany
Kai Thede 2 Berlin, Germany
Carl Friedrich NISING 2 Berlin, Germany

Michael Kröber 1 Erlin, Germany

Recent patent applications by BAYER PHARMA AKTIENGELLSCHAFT

BAYER PHARMA AKTIENGELLSCHAFT based in BERLIN, DE has been assigned the rights to these inventions. The list includes both Pending Applications and Patent Grants:

#1 | 2022-05-05 ✅ Patent 11,713,304 granted on 2023-08-01

US20220135536A1

Chemistry; metallurgy

2,4,5-trisubstituted 1,2,4-triazolones useful as inhibitors of DHODH

#2 | 2021-06-24 ✅ Patent 11,787,797 granted on 2023-10-17

US20210188846A1

Chemistry; metallurgy

4,5-annulated 1,2,4-triazolones

#3 | 2021-06-24 ✅ Patent 11,130,745 granted on 2021-09-28

US20210188805A9

Chemistry; metallurgy

2,4,5-trisubstituted 1,2,4-triazolones useful as inhibitors of DHODH

#4 | 2020-12-03 ✅ Patent 11,130,745 granted on 2021-09-28

US20200377472A1

Chemistry; metallurgy

2,4,5-trisubstituted 1,2,4-triazolones useful as inhibitors of DHODH

#5 | 2020-04-23 ✅ Patent 10,815,215 granted on 2020-10-27

US20200123129A1

Chemistry; metallurgy

2,4,5-trisubstituted 1,2,4-triazolones useful as inhibitors of DHODH

#6 | 2019-12-12 ✅ Patent 10,968,216 granted on 2021-04-06

US20190375747A1

Chemistry; metallurgy

4,5-annulated 1,2,4-triazolones

Also check out BAYER PHARMA AKTIENGELLSCHAFT's (Berlin, Germany) applicant profile with 3 patent applications submitted.

AssigneeID:

157338 ⎘